AFRICA's LEADERSHIP in COVID-19 VACCINE DEVELOPMENT and ACCESS Virtual Conference

AFRICA'S LEADERSHIP IN COVID-19 VACCINE DEVELOPMENT AND ACCESS Virtual Conference

Wednesday 24 June | 2:00 PM EAT Thursday 25 June | 1:00 PM EAT Africa's Leadership in COVID-19 Vaccine Development and Access

SCHEDULE SESSION PROGRAMME SPEAKERS (EAT)

MODERATOR

HE Amira Elfadil Mohammed Elfadil Introduction Commissioner for Social Affairs, African Union Commission, 2:00 - 2:05 PM Ethiopia Welcome Remarks HE Moussa Faki Mahamat 2:05 - 2:10 PM Chairperson, African Union Commission, Ethiopia SESSION I 2:00 - 2:45 PM Opening State of Pandemic Globally Dr Tedros Ghebreyesus 2:10 - 2:25 PM Director-General, World Health Organisation, Geneva Opening Remarks HE President Matamela Cyril Ramaphosa 2:25 - 2:30 PM Chairperson, African Union and President, Republic of South Africa The Need for Africa’s Leadership in Dr John Nkengasong COVID-19 Vaccines and Development Director, Africa Centres for Disease Control and Prevention, 2:30 - 2:45 PM Ethiopia

2:45 - 2:50 PM TECHNICAL TRANSITION TO SESSION II

CO-MODERATORS

Prof Samba Ousmane Sow Director General, Center for the Development of Vaccines in Mali, Introduction to Session II Ministry of Health, Mali 2:50 - 2:55 PM

SESSION II Prof Lynn Morris COVID-19 Vaccines Interim Director, National Institute for Communicable Diseases, 2:50 - 4:00 PM Development and Republic of South Africa Clinical Trials Needs and Requirements of Candidate Prof Salim Abdool Karim Vaccines Clinical Trials in Africa Chair of the South African Ministerial Advisory Committee for WEDNESDAY 2:55 - 3:05 PM COVID-19, Republic of South Africa 24 JUNE 2020 Candidate Vaccines Development from Dr Barney Graham US National Institute of Health Deputy Director, Vaccine Research Center and Chief, Viral 3:05 - 3:15 PM Pathogenesis Laboratory and Translational Science Core, USA

www.au.int Africa's Leadership in COVID-19 Vaccine Development and Access

SCHEDULE SESSION PROGRAMME SPEAKERS (EAT)

Dr Richard Hatchett Manufacturing of COVID-19 Vaccines 3:15 - 3:25 PM Innovations, Norway Human Research, Science and HE Prof Sarah Anyang Agbor SESSION II Technology: AU Perspectives Commissioner for Human Resources, Science and Technology, COVID-19 Vaccines 2:50 - 4:00 PM 3:25 - 3:35 PM African Union Commission, Ethiopia Development and Dr Xiao-Ping Dong Clinical Trials COVID-19 Vaccines Trials in China Director, Center for Global Public Health, Chinese Center for 3:35 - 3:45 PM Disease Control and Prevention, China Moderated Discussion and Q&A 3:45 - 4:00 PM

4:00 - 4:05 PM TECHNICAL TRANSITION TO SESSION III

CO-MODERATORS

Prof Pontiano Kaleebu Director Medical Research Council/Uganda Virus Research Institute Introduction to Session III and London School of Hygiene and Tropical Medicine, Uganda 4:05 - 4:10 PM Research Unit, Uganda

SESSION III Prof Nissaf Boua f Ben Alaya Access and Equity of Director General, National Observatory of New and Emerging 4:05 - 5:05 PM Potential COVID-19 Diseases, Tunisia Vaccines Vaccines Manufacturing in Africa Prof Amadou Sall 4:10 - 4:15 PM Director, Institut Pasteur de Dakar, Senegal Prof Senait Fisseha Gender and Access to COVID-19 Chief Advisor to the Director-General of the World Health Organisation WEDNESDAY Vaccines Director of International Programs, Susan Thompson Buffett 4:15 - 4:20 PM 24 JUNE 2020 Foundation, USA

www.au.int Africa's Leadership in COVID-19 Vaccine Development and Access

SCHEDULE SESSION PROGRAMME SPEAKERS (EAT)

Prof Daniel Bausch SESSION III Lessons from Ebola Access and Equity of Director, UK Public Health Rapid Support Team, UK 4:05 - 5:05 PM 4:20 - 4:25 PM Potential COVID-19 Vaccines Moderated Discussion and Q&A 4:25 - 5:05 PM

5:05 - 5:10 PM TECHNICAL TRANSITION TO SPECIAL SESSION I SPECIAL CO-MODERATORS SESSION I Dr Matshidiso Rebecca Moeti Introduction to Special Session I World Health Organisation Regional Director for Africa, Republic of COVID-19 Vaccines 5:10 - 5:20 PM Congo 5:10 - 6:10 PM Ministerial Panel: South Africa, Zambia, Egypt, Prof Stanley Okolo Morocco, Togo, Mali, Director General, West African Health Organisation, Burkina-Faso Cameroon, Gabon, Moderated Roundtable Discussion Kenya, Ethiopia All Ministers of Health 5:20 - 6:10 PM

6:10 - 6:15 PM TECHNICAL TRANSITION (5 min)

6:15 - 6:25 PM

6:25 PM END OF DAY 1 PROGRAMME

WEDNESDAY 24 JUNE 2020

www.au.int Africa's Leadership in COVID-19 Vaccine Development and Access

SCHEDULE SESSION PROGRAMME SPEAKERS (EAT)

CO-MODERATORS

Dr Acha Leke Introduction to Special Session II Chairman, Africa, McKinsey & Company, Republic of South Africa 1:00 - 1:05 PM Mr Cheikh Oumar Seydi Director Africa, Bill and Melinda Gates Foundation, Republic of South Africa Dr Vera Songwe Needs for Private Sector Engagement UN Under-Secretary General and Executive Secretary, United 1:05 - 1:10 PM Nations Economic Commission for Africa, Ethiopia SPECIAL Advocacy for Potential COVID-19 Dr Timothy Mastro SESSION II Vaccines in Resource Limited Settings 1:10 - 1:15 PM Role of the Private Role of Gavi in Ensuring Access to a 1:00 - 2:00 PM Sector in COVID-19 Dr Seth Berkley COVID-19 Vaccine Vaccines Development Geneva and Access 1:15 - 1:20 PM Afreximbank’s Innovative Financing for Dr Benedict Oramah Vaccines Development in Africa President African Export – Import Bank (Afreximbank), Egypt 1:20 - 1:25 PM Financing Options for Potential Dr Olusoji Adeyi COVID-19 Vaccines in Africa Senior Advisor for Human Development and Former Director of 1:25 - 1:30 PM Health at the World Bank, USA Innovations to Enable Development and Access to COVID-19 Vaccines in Mr Strive Masiyiwa Africa Executive Chairman and Founder of Econet Group, Zimbabwe 1:30 - 1:35 PM THURSDAY Roundtable Discussion and Q&A 25 JUNE 2020 1:35 - 2:00 PM

2:00 - 2:05 PM TECHNICAL TRANSITION TO SESSION IV

www.au.int Africa's Leadership in COVID-19 Vaccine Development and Access

SCHEDULE SESSION PROGRAMME SPEAKERS (EAT)

CO-MODERATORS Prof Jean-Jacques Muyembe-Tamfum Introduction to Session IV Director General, National Institute for Biomedical Research, 2:05 - 2:10 PM Democratic Republic of Congo

Dr Chikwe Ihekweazu Director General, Nigeria Centre for Disease Control, Nigeria Using Past Experience to Inform Prof Helen Rees Thinking to Potential COVID-19 Executive Director, Wits Reproductive Health and HIV Institute of Vaccines the University of the Witwatersrand in Johannesburg, Republic of 2:10 - 2:15 PM South Africa

SESSION IV Role of African Vaccines Regulatory Prof William Ampofo COVID-19 Vaccines: Forum in COVID-19 Vaccine Development Noguchi Memorial Ins titute for Medical Research, Ghana 2:05 - 3:05 PM Regulatory, Ethical 2:15 - 2:20 PM and Community Community Engagement Strategies for Dr Githinji Gitahi Engagement COVID-19 Vaccines Clinical Trials 2:20 - 2:25 PM Kenya Good Participatory Practice Guidelines Prof Linda-Gail Bekker for Trials of Emerging (and Re-Emerging) Deputy Director, Desmund Tutu HIV Centre at the University of Pathogens Cape Town, Republic of South Africa 2:25 - 2:30 PM Africa Medicine Agency and Vaccine Dr Margaret Agama-Anyetei Regulation in Africa Head of Division, Health Nutrition and Population, Department of 2:30 - 2:35 PM Social Affairs, African Union Commission, Ethiopia

Exiting Regulatory Processes Within the Mr Amine Idriss Adoum AU to Facilitate Vaccine Uptake Director, Directorate of Programme Delivery and Coordination, 2:35 - 2:40 PM The African Union Development Agency (AUDA-NEPAD) THURSDAY Moderated Discussion and Q&A 25 JUNE 2020 2:40 - 3:05 PM

3:05 - 3:10 PM TECHNICAL TRANSITION TO SESSION V

www.au.int Africa's Leadership in COVID-19 Vaccine Development and Access

SCHEDULE SESSION PROGRAMME SPEAKERS (EAT)

CO-MODERATORS

Prof Abderrahmane Maarou Director, Institut Pasteur Maroc, Morocco Introduction to Session V

3:10 - 3:15 PM Prof Francine Ntoumi Chair and Executive Director of the Congolese Foundation for Medical Research, Republic of Congo SESSION V Anthropological Considerations for Prof Heidi J. Larson COVID-19 Vaccines: COVID-19 Vaccines Development and 3:10 - 4:10 PM Anthropological, Access Hygiene & Tropical Medicine, UK Sociological 3:15 - 3:25 PM Perspectives African Behavioural Insights to Inform Dr Hana Rohan COVID-19 Vaccines Adoption Assistant Professor in Social Sciences, UK Public Health Rapid 3:25 - 3:35 PM Support Team, London School of Hygiene and Tropical Medicine, UK COVID-19 Vaccines Trials in Africa: Perspectives from African Academy of Prof Tom Kariuki Science Director of Programmes, The African Academy of Science, Kenya 3:35 - 3:45 PM Moderated Discussion and Q&A 3:45 - 4:10 PM

4:10 - 4:15 PM TECHNICAL TRANSITION TO SPECIAL SESSION III

THURSDAY 25 JUNE 2020

www.au.int Africa's Leadership in COVID-19 Vaccine Development and Access

SCHEDULE SESSION PROGRAMME SPEAKERS (EAT)

CO-MODERATORS

Dr Ebere Okereke Introduction to Special Session III Consultant in Global Public Health, Public Health England, UK 4:15 - 4:20 PM Dr Alex Coutinho Consultant, Public Health, Uganda Role of Risk Communication in Ms Ebba Kalondo Vaccines Acceptance Spokesperson to the Chairperson, African Union Commission, 4:20 - 4:25 PM Ethiopia Current Vaccines Manufacturing SPECIAL Dr Simon Agwale Capacity in Africa SESSION III 4:25 - 4:30 PM 4:15 - 5:15 PM Communication and Media perspective Mrs Anne Soy Civil Society 4:30 - 4:35 PM Deputy Africa Editor & Senior Correspondent, BBC Media perspective Mr Samuel Gebre 4:35 - 4:40 PM Journalist, Bloomberg News Religious perspective Sheikh Abdullatif Abdulkarim 4:40 - 4:45 PM Religious perspective Bishop David Njovu 4:45 - 4:50 PM Diocese of Lusaka Testimonial on Surviving COVID-19 Rev Wainaina 4:50 - 4:55 PM Provost of All Saints Cathedral Roundtable Discussion and Q&A 4:55 - 5:15 PM THURSDAY 5:15 - 5:20 PM TECHNICAL TRANSITION TO SESSION VI 25 JUNE 2020

www.au.int Africa's Leadership in COVID-19 Vaccine Development and Access

SCHEDULE SESSION PROGRAMME SPEAKERS (EAT)

What is Needed for Equitable Access to Ms Winnie Byanyima COVID-19 Vaccines in Africa? Executive Director, The Joint United Nations Programme on HIV/ 5:20 - 5:25 PM AIDS, Geneva Dr John Nkengasong Summary and Way Forward Director, Africa Centres for Disease Control and Prevention, 5:25 - 5:35 PM Ethiopia Closing Remarks HE Amira Elfadil Mohammed Elfadil 5:35 - 5:40 PM Commissioner for Social Affairs, African Union Commission, Ethiopia SESSION VI 5:20 - 7:00 PM Closing HE Amira Elfadil Mohammed Elfadil Reading of the Communique 5:40 - 5:50 PM Commissioner for Social Affairs, African Union Commission, Ethiopia HE Amira Elfadil Mohammed Elfadil Commissioner for Social Affairs, African Union Commission, Ethiopi a Press Conference 6:00 - 7:00 PM Dr John Nkengasong Director, Africa Centres for Disease Control and Prevention, Ethiopia

END OF DAY 2 PROGRAMME

THURSDAY 25 JUNE 2020